Another clinical trial (NCT04499365) plans to enroll 500 patients for 68Ga-FAPI-04 PET to provide robust clinical data regarding the use of FAP-targeted imaging to diagnose and monitor cancer [79]. The gene discussed is FAP; the disease is cancer.